"Designing Growth Strategies is in our DNA"

CAR-T Cell Therapy Market Size, Share & Industry Analysis, By Drug Type (Axicabtagene Ciloleucel (Yescarta), Brexucabtagene Autoleucel (Tecartus), Ciltacabtagene Autoleucel (Carvykti), Idecabtagene Vicleucel (Abecma), Lisocabtagene Maraleucel (Breyanzi), Tisagenlecleucel (Kymriah), and Others), By Indication (Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma, and Multiple Myeloma), By End-user (Hospitals and Oncology Treatment Centers), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI108455

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Chronic Diseases, by Key Countries/Regions, 2024/2025
    2. Pipeline Analysis, By Key Players
    3. Technological Advancements
    4. New Product Launches, By Key Players
    5. Key Industry Developments: Mergers, Acquisitions & Partnerships
    6. Impact of COVID-19 on the Market
  5. Global CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
    4. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. Gilead Sciences, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Bristol-Myers Squibb Company
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Johnson & Johnson Services, Inc. (Janssen Global Services, LLC)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Caribou Biosciences, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. CARsgenTherapeutics Co., Ltd
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. JW Therapeutics (Shanghai) Co., Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Cartesian Therapeutics, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Aurora Biopharma
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Chronic Diseases, by Key Countries/Regions, 2024/2025
    2. Pipeline Analysis, By Key Players
    3. Technological Advancements
    4. New Product Launches, By Key Players
    5. Key Industry Developments: Mergers, Acquisitions & Partnerships
    6. Impact of COVID-19 on the Market
  5. Global CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
    4. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Axicabtagene Ciloleucel (Yescarta)
      2. Brexucabtagene Autoleucel (Tecartus)
      3. Ciltacabtagene Autoleucel (Carvykti)
      4. Idecabtagene Vicleucel (Abecma)
      5. Lisocabtagene Maraleucel (Breyanzi)
      6. Tisagenlecleucel (Kymriah)
      7. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Acute lymphoblastic leukemia
      2. Non-Hodgkin lymphoma
      3. Multiple Myeloma
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Oncology Treatment Centers
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. Gilead Sciences, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Bristol-Myers Squibb Company
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Johnson & Johnson Services, Inc. (Janssen Global Services, LLC)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Caribou Biosciences, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. CARsgenTherapeutics Co., Ltd
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. JW Therapeutics (Shanghai) Co., Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Cartesian Therapeutics, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Aurora Biopharma
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global CAR-T Cell Therapy Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global CAR-T Cell Therapy Market Value Share (%), By Drug Type, 2025 & 2034

Figure 3: Global CAR-T Cell Therapy Market Value Share (%), By Indication, 2025 & 2034

Figure 4: Global CAR-T Cell Therapy Market Value Share (%), By End User, 2025 & 2034

Figure 5: Global CAR-T Cell Therapy Market Value Share (%), By Region, 2025 & 2034

Figure 6: North America CAR-T Cell Therapy Market Value (USD billion), By Drug Type, 2025 & 2034

Figure 7: North America CAR-T Cell Therapy Market Value Share (%), By Drug Type, 2025

Figure 8: North America CAR-T Cell Therapy Market Value (USD billion), By Indication, 2025 & 2034

Figure 9: North America CAR-T Cell Therapy Market Value Share (%), By Indication, 2025

Figure 10: North America CAR-T Cell Therapy Market Value (USD billion), By End User, 2025 & 2034

Figure 11: North America CAR-T Cell Therapy Market Value Share (%), By End User, 2025

Figure 12: North America CAR-T Cell Therapy Market Value (USD billion), by Country, 2025 & 2034

Figure 13: North America CAR-T Cell Therapy Market Value Share (%), by Country, 2025

Figure 14: Europe CAR-T Cell Therapy Market Value (USD billion), By Drug Type, 2025 & 2034

Figure 15: Europe CAR-T Cell Therapy Market Value Share (%), By Drug Type, 2025

Figure 16: Europe CAR-T Cell Therapy Market Value (USD billion), By Indication, 2025 & 2034

Figure 17: Europe CAR-T Cell Therapy Market Value Share (%), By Indication, 2025

Figure 18: Europe CAR-T Cell Therapy Market Value (USD billion), By End User, 2025 & 2034

Figure 19: Europe CAR-T Cell Therapy Market Value Share (%), By End User, 2025

Figure 20: Europe CAR-T Cell Therapy Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 21: Europe CAR-T Cell Therapy Market Value Share (%), by Country/ Sub-Region, 2025

Figure 22: Asia Pacific CAR-T Cell Therapy Market Value (USD billion), By Drug Type, 2025 & 2034

Figure 23: Asia Pacific CAR-T Cell Therapy Market Value Share (%), By Drug Type, 2025

Figure 24: Asia Pacific CAR-T Cell Therapy Market Value (USD billion), By Indication, 2025 & 2034

Figure 25: Asia Pacific CAR-T Cell Therapy Market Value Share (%), By Indication, 2025

Figure 26: Asia Pacific CAR-T Cell Therapy Market Value (USD billion), By End User, 2025 & 2034

Figure 27: Asia Pacific CAR-T Cell Therapy Market Value Share (%), By End User, 2025

Figure 28: Asia Pacific CAR-T Cell Therapy Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 29: Asia Pacific CAR-T Cell Therapy Market Value Share (%), by Country/ Sub-Region, 2025

Figure 30: Rest of the World CAR-T Cell Therapy Market Value (USD billion), By Drug Type, 2025 & 2034

Figure 31: Rest of the World CAR-T Cell Therapy Market Value Share (%), By Drug Type, 2025

Figure 32: Rest of the World CAR-T Cell Therapy Market Value (USD billion), By Indication, 2025 & 2034

Figure 33: Rest of the World CAR-T Cell Therapy Market Value Share (%), By Indication, 2025

Figure 34: Rest of the World CAR-T Cell Therapy Market Value (USD billion), By End User, 2025 & 2034

Figure 35: Rest of the World CAR-T Cell Therapy Market Value Share (%), By End User, 2025

Figure 36: Global CAR-T Cell Therapy Market Share (%), By Company, 2025

Table 1: Global CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Drug Type, 2021-2034

Table 2: Global CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034

Table 3: Global CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 4: Global CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 5: North America CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Drug Type, 2021-2034

Table 6: North America CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034

Table 7: North America CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 8: North America CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 9: Europe CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Drug Type, 2021-2034

Table 10: Europe CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034

Table 11: Europe CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 12: Europe CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 13: Asia Pacific CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Drug Type, 2021-2034

Table 14: Asia Pacific CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034

Table 15: Asia Pacific CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By End User, 2021–2034

Table 16: Asia Pacific CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 17: Rest of the World CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Drug Type, 2021-2034

Table 18: Rest of the World CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By Indication, 2021-2034

Table 19: Rest of the World CAR-T Cell Therapy Market Revenue (USD billion) Forecast, By End User, 2021–2034

CAR-T Cell Therapy Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 149
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports